VentriPoint Diagnostics (TSXV: VPT) (OTCPK: VPTDF) just locked in a new healthcare partnership in Central America. The Toronto-based medtech company announced a collaboration with the Health Division ...
BACKGROUND: Genetic variants in components or regulators of the RAS-MAPK signaling pathway are causative for severe and early-onset hypertrophic cardiomyopathy (HCM) in patients with Noonan syndrome ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results